WHO warns of gaps in antimicrobial resistance response despite growing national action
The World Health Organization (WHO) has warned that major gaps in diagnosis, treatment and funding continue to put patients at risk from antimicrobial resistance (AMR), despite a growing number of countries adopting national action plans to tackle the threat.
According to new WHO data released ahead of World AMR Awareness Week, 173 countries have developed national plans to address antimicrobial resistance, more than double the 79 countries that reported having such plans in 2017.
However, only 22% of countries have secured the necessary funding and fully implemented their national action plans, leaving significant weaknesses in infection prevention, diagnosis, treatment and disease surveillance.
Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites no longer respond effectively to medicines, making infections harder to treat and increasing the risks associated with routine medical procedures, childbirth, surgery and cancer treatment.
In 2023, approximately one in six laboratory-confirmed bacterial infections worldwide was resistant to antibiotics, highlighting the growing threat to public health.
"National plans are essential for protecting the medicines that protect us, and the fact that most countries now have plans in place is great news," WHO Director-General Tedros Adhanom Ghebreyesus said.
"But an unfulfilled plan helps no one," he added, urging governments to invest in infection prevention, disease surveillance, equitable access to essential antimicrobial medicines and reliable diagnostic services.
The findings are based on the 2026 Tracking Antimicrobial Resistance Country Self-assessment Survey (TrACSS), which was completed by 183 countries, representing 94% of WHO member states.
Diagnostic testing and surveillance remain major weaknesses
The WHO warned that inadequate diagnostic capacity remains one of the biggest obstacles to tackling drug-resistant infections.
Only 36% of countries reported having a national reference laboratory capable of testing selected bacterial and fungal infections, falling well short of the global target of 80% by 2030.
Limited access to diagnostic testing increases the risk of patients receiving ineffective or unnecessary antibiotics. It also makes it harder to detect resistant infections and outbreaks and identify emerging resistance patterns.
The report also found that only 63% of countries had guidelines for the appropriate use of antimicrobial medicines, while just over half had surveillance systems to monitor national antibiotic consumption and track antimicrobial resistance.
To help address these shortcomings, the WHO has introduced two practical tools under its AMR Diagnostic Initiative. The resources provide a prioritized catalogue of diagnostic tests and step-by-step guidance to help clinical laboratories identify bacterial and fungal infections.
WHO calls for coordinated global action
The findings come ahead of World AMR Awareness Week, which will take place from November 18 to 24 under the theme "One Health, one action: Prevent AMR now."
The annual campaign seeks to raise public awareness and encourage coordinated efforts to prevent the emergence and spread of drug-resistant infections.
This year's theme highlights the interconnected health of humans, animals, plants and the environment, calling on governments, farmers, veterinarians, environmental specialists and communities to work together against antimicrobial resistance.
The WHO stressed that preventing infections, strengthening diagnostic services and ensuring the responsible use of antimicrobial medicines are essential to slowing the spread of drug resistance and protecting the effectiveness of life-saving treatments. (ILKHA)
LEGAL WARNING: All rights of the published news, photos and videos are reserved by İlke Haber Ajansı Basın Yayın San. Trade A.Ş. Under no circumstances can all or part of the news, photos and videos be used without a written contract or subscription.
A child health and diseases specialist stated that 12 per cent of babies in Türkiye are born prematurely, emphasizing that delivery at the right medical center, timely intervention and regular follow-up are crucial for premature infants.
The number of Ebola infections in the Democratic Republic of the Congo (DRC) has exceeded 11,000, with the death toll climbing to 5,387, according to the country's Health Ministry.
The number of measles cases in the United States has surpassed 5,000 this year, reaching its highest level in 35 years, as outbreaks continue to spread across the country and health officials report additional deaths.